Kimberly J. Jenko

发表

In vitro and in vivo evaluation of 11C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors

Masahiro Fujita, Robert B. Innis, Victor W. Pike, 2014, NeuroImage.

Comparison of human plasma arterial input function for [11C]MePPEP determined with LC-MS/MS and radiometric methods

Cheryl L. Morse, Robert B. Innis, Victor W. Pike, 2010, NeuroImage.

On the quantitative relationship between radiotracer lipophilicity and plasma free fraction

Robert B. Innis, Victor W. Pike, Sami S. Zoghbi, 2010, NeuroImage.

Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker

Masahiro Fujita, Cheryl L. Morse, Robert B. Innis, 2010, NeuroImage.

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

Francis J McMahon, Nobuyo Kimura, Sami S Zoghbi, 2013, Brain : a journal of neurology.

11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease

Jeih-San Liow, Cheryl L. Morse, Robert B. Innis, 2016, Neurobiology of Aging.

Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease

Jeih-San Liow, Cheryl L. Morse, Robert B. Innis, 2017, Neurobiology of Aging.

Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia

Robert B. Innis, Sami S. Zoghbi, Jussi Hirvonen, 2012, Schizophrenia Research.

In vitro and in vivo evaluation of 11 CSD 5024 , a novel PET radioligand for human brain imaging of cannabinoid CB 1 receptors ☆ O F

Sean R. Donohue, Kimberly J. Jenko, C. Halldin, 2013 .

Development of N-Methyl-(2-arylquinolin-4-yl)oxypropanamides as Leads to PET Radioligands for Translocator Protein (18 kDa)

Kimberly J. Jenko, S. Zoghbi, V. Pike, 2014, Journal of medicinal chemistry.

Synthesis and Evaluation of Translocator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971

Kimberly J. Jenko, F. Da Settimo, S. Taliani, 2014, ACS chemical neuroscience.

2-(4-Methylsulfonylphenyl)pyrimidines as Prospective Radioligands for Imaging Cyclooxygenase-2 with PET—Synthesis, Triage, and Radiolabeling

Kimberly J. Jenko, S. Zoghbi, V. Pike, 2018, Molecules.

Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.

Kimberly J. Jenko, S. Zoghbi, J. Liow, 2012, Journal of medicinal chemistry.

Synthesis of PET radioligands as potential probes for imaging COX-2 in neuroinflammation

Kimberly J. Jenko, S. Zoghbi, V. Pike, 2015 .

[18F]PS-2 as a candidate radioligand for imaging COX-1 expression in brain: radiosynthesis and monkey PET imaging

Kimberly J. Jenko, S. Zoghbi, R. Gladding, 2015 .

3-Substituted 1,5-Diaryl-1 H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 1: Synthesis and Pharmacology.

Kimberly J. Jenko, S. Zoghbi, V. Pike, 2018, ACS chemical neuroscience.

Conjugated Linoleic Acids and CLA-Containing Phospholipids Inhibit NO Formation in Aortic Endothelial Cells

Kimberly J. Jenko, J. Vanderhoek, 2008, Lipids.

Translocator protein ligands based on N-methyl-(quinolin-4-yl)oxypropanamides with properties suitable for PET radioligand development.

Kimberly J. Jenko, S. Zoghbi, V. Pike, 2016, European journal of medicinal chemistry.

Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein.

Kimberly J. Jenko, S. Inati, J. Hirvonen, 2015, JAMA neurology.

Subanesthetic IV ketamine reduces acute suicidal ideation in patients with mood disorders

Kimberly J. Jenko, Jack Anzilotti, 2019 .

Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?

Talakad G. Lohith, Kimberly J. Jenko, M. Bear, 2013, Molecular Autism.

11C-CUMI-101, a PET Radioligand, Behaves as a Serotonin 1A Receptor Antagonist and Also Binds to α1 Adrenoceptors in Brain

Jeih-San Liow, Shuiyu Lu, Per Svenningsson, 2014, The Journal of Nuclear Medicine.

Neuroinflammation in frontotemporal lobar degeneration revealed by 11C‐PBR28 PET

Kimberly J. Jenko, S. Zoghbi, V. Pike, 2019, Annals of clinical and translational neurology.

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

Kimberly J. Jenko, F. McMahon, J. Kleinman, 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Human Brain Imaging and Radiation Dosimetry of 11C-N-Desmethyl-Loperamide, a PET Radiotracer to Measure the Function of P-Glycoprotein

Jeih-San Liow, Peter Herscovitch, Nicholas Seneca, 2009, Journal of Nuclear Medicine.

The 5-HT1A Receptor PET Radioligand 11C-CUMI-101 Has Significant Binding to α1-Adrenoceptors in Human Cerebellum, Limiting Its Use as a Reference Region

Kimberly J. Jenko, S. Zoghbi, J. Liow, 2016, Journal of Nuclear Medicine.

[carbonyl-11C]4-Fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([11C]FIMX) is an effective radioligand for PET imaging of metabotropic glutamate receptor 1 (mGluR1) in monkey brain.

Kimberly J. Jenko, S. Zoghbi, J. Liow, 2015, Nuclear medicine and biology.

On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human.

Sami S Zoghbi, Victor W Pike, Robert B Innis, 2012, Journal of pharmaceutical sciences.

In vitro and in vivo evaluation of 11C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors

Sean R. Donohue, Kimberly J. Jenko, C. Halldin, 2014, NeuroImage.

Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia

Kimberly J. Jenko, J. Kleinman, J. Hirvonen, 2012, Schizophrenia Research.